Effects of a thyromimetic on apolipoprotein B-100 in rats.
J. Mol. Endocrinol., Dec;25(3):299-308 (2000)
Beneficial effects of a novel thyromimetic on lipoprotein metabolism.
Mol. Pharmacol., Sep;52(3):542-7 (1997)
Demonstration of potent lipid-lowering activity by a thyromimetic agent devoid of cardiovascular and thermogenic effects.
Atherosclerosis., Sep;126(1):53-63 (1996)
Effects of altered endocrine function on biliary metabolites of [4-14C]androst-4-ene-3,17-dione in rats. Possible utility as a model for identifying anti-atherosclerotic agents.
Atherosclerosis., Jan;54(1):11-21 (1985)
Epithelial organization and hormone sensitivity of toad urinary bladder cells in culture.
Am. J. Physiol., Aug;241(2):F129-38 (1981)
Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid.
Biochem. Pharmacol., May;43(9):1969-74 (1992)